A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia
NCT00117039
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1500
Enrollment
INDUSTRY
Sponsor class
Conditions
Anemia
Neoplasms
Interventions
DRUG:
Aranesp®
Sponsor
Amgen